Clinical Trials Browser

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04242823 2026-04-15

Primary HPV-based Cervical Cancer Screening Algorithms in Botswana

Phase NA Active not recruiting

3,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06874985 2026-04-03

Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation

Phase NA Active not recruiting

1,120 enrolled

BreastGynecologicHead & Neck

Breast Neoplasms, Uterine Cervical Neoplasms, Mouth Neoplasms

NCT05645146 2026-04-01

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Phase NA Active not recruiting

360 enrolled

Gynecologic

Uterine Cervical Neoplasms, Smoking Cessation

NCT01977274 2026-03-31

GC-BIO

Phase NA Active not recruiting

300 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06010160 2026-03-20

GC-CCP

Phase NA Active not recruiting

1,400 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06286462 2026-03-16

CATSystem

Phase NA Active not recruiting

6,600 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04266886 2026-03-13

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

Phase NA Active not recruiting

152 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01181375 2026-03-05

Predictive Assays In Cervix Cancer

Phase NA Active not recruiting

500 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT06263283 2026-02-24

KYOCOL

Phase NA Active not recruiting

98 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05656976 2026-02-17

ESSAG

Phase NA Active not recruiting

3,375 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03984695 2026-01-28

SHE-WOMEN

Phase NA Active not recruiting

279 enrolled 17 charts

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Contraception Behavior, Sexually Transmitted Diseases

NCT05786456 2026-01-28

e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

Phase NA Active not recruiting

23 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06411938 2026-01-16

Merck-3

Phase NA Active not recruiting

2,300 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06796738 2026-01-16

Advancing Cervical Cancer Screening Through the Emergency Department - IIS

Phase NA Active not recruiting

200 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03955185 2025-12-31

CGOG 002

Phase NA Active not recruiting

2,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05220033 2025-12-30

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Phase NA Active not recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06611540 2025-12-30

LMI-001-A-S03

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2025-12-15

LMI-001-A-S02

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07273383 2025-12-09

HPVselftest

Phase NA Active not recruiting

1,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06572774 2025-11-24

C3Link

Phase NA Active not recruiting

5,400 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT06002126 2025-11-14

ULACNet-202

Phase NA Active not recruiting

1,002 enrolled

Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06577220 2025-10-14

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Phase NA Active not recruiting

111 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04452526 2025-08-26

IVaccinate

Phase NA Active not recruiting

372 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05996783 2025-06-13

ScreenUrSelf

Phase NA Active not recruiting

48,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05994300 2025-06-08

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Phase NA Active not recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms, Radiation Injuries

NCT06452004 2025-04-04

AI-DSS

Phase NA Active not recruiting

600 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06402383 2025-03-20

Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV

Phase NA Active not recruiting

2,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05243888 2025-02-05

CapU4

Phase NA Active not recruiting

15,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03239626 2025-01-03

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Phase NA Active not recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02642471 2024-12-16

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)

Phase NA Active not recruiting

1,080 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06082882 2024-12-12

SEMM2

Phase NA Active not recruiting

8,000 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT06697054 2024-11-20

SLN

Phase NA Active not recruiting

60 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05139368 2024-11-18

RT-PACE

Phase NA Active not recruiting

22 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06598085 2024-09-19

Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery

Phase NA Active not recruiting

20 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03386734 2024-07-08

SENTICOLIII

Phase NA Active not recruiting

989 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01549730 2024-06-18

Cervix Hypoxia FAZA

Phase NA Active not recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01511328 2024-05-16

Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm

Phase NA Active not recruiting

270,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Compass

Primary HPV-based Cervical Cancer Screening Algorithms in Botswana

Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

GC-BIO

GC-CCP

CATSystem

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

Predictive Assays In Cervix Cancer

KYOCOL

ESSAG

SHE-WOMEN

e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

Merck-3

Advancing Cervical Cancer Screening Through the Emergency Department - IIS

CGOG 002

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

LMI-001-A-S03

LMI-001-A-S02

HPVselftest

C3Link

ULACNet-202

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

IVaccinate

ScreenUrSelf

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

AI-DSS

Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV

CapU4

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)

SEMM2

SLN

RT-PACE

Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery

SENTICOLIII

Cervix Hypoxia FAZA

Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm